Large gap with delayed quotes
Analysis date: 08.07.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 07.02.2025.
Interest
Very strong
Very strong
Four stars since 20.06.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 20.06.2025 at a price of 66.50.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Positive
Positive
The forty day technical trend is positive since 25.04.2025.
4wk Rel Perf
15.23%
15.23%
The four-week dividend-adjusted overperformance versus STOXX600 is 15.23%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 03.01.2025.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.81%.
Mkt Cap in $bn
3.47
3.47
With a market capitalization between $2 & $8bn, MELEXIS is considered a mid-cap stock.
G/PE Ratio
1.44
1.44
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
15.19
15.19
The estimated PE is for the year 2027.
LT Growth
16.77%
16.77%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
10
10
Over the last seven weeks, an average of 10 analysts provided earnings per share estimates.
Dividend Yield
5.04%
5.04%
The twelve month estimated dividend yield represents 76.59% of earnings forecasts.
Beta
147
147
For 1% of index variation, the stock varies on average by 1.47%.
Correlation
0.56
0.56
55.89% of stock movements are explained by index variations.
Value at Risk
17.62
17.62
The value at risk is estimated at EUR 17.62. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002